Which of the following best describes the benefit of introducing unlisted infrastructure in a portfolio? O a. Provides resilient qualities and relatively low correlation to equity markets O b. Provides idiosyncratic risk exposure O c. Provides environmental benefits O d. Provides liquidity to the portfolio in a market stressed environment Which valuation method would be most appropriate for valuing a newly established biotech company which is specializing in looking to identify and commercialise a vaccine to address COVID19 and other related diseases? The company goal is delivery of a safe and effective COVID-19 vaccine and treatment for a global market. The company has commenced initial Phase 1 clinical trials on a vaccine and is expected to grow rapidly next year, if these provide successful and receive regulatory approval, but is yet to report any client revenue. a. EBITDA multiple b. Capital expenditure c. Discounted cash flow (DCF) O d. Book value